| Research
> Anemia > IV
Iron |
|
Because it can help raise hematocrit levels, I.V. iron is frequently used in the treatment of anemia. We have begun to explore the relationship between patient health and the way in which I.V. iron is administered (how often and how much). Our initial studies show that the amount of iron and the frequency with which it is given appear to have an effect on how long you live. It appears that it is more beneficial to administer IV iron less often and in higher doses (as compared to more often and in smaller amounts). We are currently conducting more studies to confirm these findings.
|
Hematocrit, erythropoietin, and iron use trends in hemodialysis and peritoneal dialysis patients
American Society of Nephrology, October 2001 |
| View
Presentation - Download |
Effect of intravenous iron use on erythropoietin doses & hematocrit levels in prevalent hemodialysis patients
American Society of Nephrology, October 2001 |
| View
Presentation - Download |
Infectious Hospitalization Risk in IV Iron-Treated Patients.
American Society of Nephrology, November 1999 |
| View Presentation - Download |
Association Between Iron Dosing Patterns & Antibiotic Use
International Congress of Nephrology, Apr 1999 |
| View
Presentation - Download |
I.V. Iron Dosing Patterns & Hospitalization
American Society of Nephrology, October 1997 |
| View Presentation - Download |
I.V. Iron Dosing Patterns & Mortality
American Society of Nephrology, October 1998 |
| View Presentation - Download |
Frequent I.V. Iron Dosing is Associated with Higher Rates of Infectious Death
American Society of Nephrology, November 1997 |
| View Presentation - Download |
